Institutional Ownership Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN). We have compiled data on the 12 institutions that hold shares in the stock, with a total of 194,892 shares, which have been reported (via 13F filing form) to have a value of $370,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
50,501
shares
|
$95,951
0.0% of portfolio
|
Q1 2025
Reduced 50.77%
|
|
|
Meitav Dash Investments LTD
|
May 12, 2025 Q1 2025 |
40,000
shares
|
$76,000
0.0% of portfolio
|
Q2 2024
Reduced 20.0%
|
|
|
Xtx Topco LTD
London, X0 |
May 07, 2025 Q1 2025 |
33,706
shares
|
$64,041
0.0% of portfolio
|
Q1 2025
Reduced 19.55%
|
|
|
Commonwealth Equity Services, LLC
|
May 09, 2025 Q1 2025 |
17,250
shares
|
$32,775
0.0% of portfolio
|
Q1 2025
Added 6.15%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
15,870
shares
|
$30,153
0.0% of portfolio
|
Q4 2024
Added 32.66%
|
|
|
Two Sigma Securities, LLC
New York, NY |
May 15, 2025 Q1 2025 |
14,705
shares
|
$27,939
0.0% of portfolio
|
Q1 2025
Reduced 2.08%
|
|
|
Warberg Asset Management LLC
Winnetka, IL |
May 09, 2025 Q1 2025 |
10,700
shares
|
$20,330
0.1% of portfolio
|
Q4 2024
New holding
|
|
|
Hurley Capital, LLC
New York, NY |
May 07, 2025 Q1 2025 |
8,710
shares
|
$16,549
0.01% of portfolio
|
Q1 2025
New holding
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
2,275
shares
|
$4,322
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Cwm, LLC
|
May 01, 2025 Q1 2025 |
1,000
shares
|
$1,900
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
175
shares
|
$332
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|